NEW YORK, NY, Axoni, a leading provider of enterprise blockchain technology, announced today the completion of a $32 million Series B financing round. Read More
BOSTON, MA, Orchard Therapeutics has raised a further $150 million to fund its work in gene therapy, building on earlier fundraisings worth more than $140 million. Read More
SAN MATEO, CA, Exabeam, the next-gen security information and event management company, today announced that it has closed $50 million in Series D funding. Read More
BOSTON, MA, meQuilibrium, the leading human capital solution grounded in the science of resilience, announced $7 million in Series C funding. Read More